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Abstract 
Study Objective: Sleep is reflected not only in the electroencephalogram but also in heart rhythms and 
breathing patterns. Therefore, we hypothesize that it is possible to accurately stage sleep based on the 
electrocardiogram (ECG) and respiratory signals. 
Methods: Using a dataset including 8,682 polysomnographs, we develop deep neural networks to stage 
sleep from ECG and respiratory signals. Five deep neural networks consisting of convolutional networks 
and long short-term memory networks are trained to stage sleep using heart and breathing, including 
the timing of R peaks from ECG, abdominal and chest respiratory effort, and the combinations of these 
signals. 
Results: ECG in combination with the abdominal respiratory effort achieve the best performance for 
staging all five sleep stages with a Cohen’s kappa of 0.600 (95% confidence interval 0.599 – 0.602); and 
0.762 (0.760 – 0.763) for discriminating awake vs. rapid eye movement vs. non-rapid eye movement 
sleep. The performance is better for young participants and for those with a low apnea-hypopnea index, 
while it is robust for commonly used outpatient medications. 
Conclusions: Our results validate that ECG and respiratory effort provide substantial information about 
sleep stages in a large population. It opens new possibilities in sleep research and applications where 
electroencephalography is not readily available or may be infeasible, such as in critically ill patients. 
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Introduction 
Characterizing sleep has primarily relied on the analysis of the electroencephalogram (EEG), 
supplemented by the electrooculogram and chin electromyogram 1. Three distinct states are readily 
discernable through such analysis: wake, rapid eye movement sleep (REM) and non-REM sleep (NREM) 
1. Three stages of progressive depth (N1, N2, and N3) can be differentiated in NREM 1. EEG slow-wave 
oscillations (about 1 – 4Hz) dominate deeper NREM sleep, while sleep spindles (about 10 – 13 Hz) and 
theta wave oscillations (about 4 – 8Hz) dominate lighter NREM sleep 1. 
Cortical, subcortical, and brainstem systems are highly interactive throughout sleep 2-6, and their activity 
couples autonomic activity with the cortical activity measurable by EEG. Examples include strong sinus 
arrhythmia 3, blood pressure dipping 7, and stable breathing or stable flow-limitation 8. REM sleep is 
characterized by highly recognizable respiratory rate and tidal volume fluctuations, and by surges in 
heart rate and blood pressure 9. Wake demonstrates dominance of low-frequency heart rate variability 
and large amplitude movements. These observations suggest that accurate sleep staging might be 
possible from non-EEG signals influenced by the autonomic nervous system, such as the ECG or 
respiratory signals. 
An accurate non-EEG method for staging state characterization would have several advantages. For 
example, the ECG is recorded continuously in numerous medical and situations, especially in 
hospitalized patients. Wearable devices increasingly measure ECG and respiration 10-12. Cardiorespiratory 
signals may be obtainable in a number of ways, including contact recordings such as Withings, 
ballistocardiogram 13, or non-contact radar-type applications such as EarlySense 14, and SleepScore 15, 
etc. On the other hand, EEG can be highly abnormal in medically ill populations, making standard 
analysis difficult 16. 
Deep learning approaches can be used to accurately estimate sleep states. We previously showed that 
deep neural networks can learn to score conventional sleep stages based on EEG signals obtained during 
overnight PSG with an accuracy of 87.5% and a Cohen’s kappa of 0.805, comparable to the performance 
of human sleep scoring experts 17. Here we develop deep neural networks using ECG and/or respiratory 
signals to classify sleep stages. Our approach is based on convolutional neural network (CNN) in 
combination with long-short term memory (LSTM) recurrent neural network. It is trained on a large 
clinical dataset, which also accounts for patient heterogeneity, spanning a wide range of ages, 
medications and sleep disorders. 
 
Methods 
Dataset 
The Partners Institutional Review Board approved retrospective analysis of polysomnograms (PSG), 
acquired in the Sleep Laboratory at Massachusetts General Hospital from 2009 to 2016, without 
requiring additional consent for use in this study. PSGs were recorded adhering to American Academy of 
Sleep Medicine (AASM) standards. Each PSG includes one ECG channel and two respiratory effort 
channels recorded from chest and abdomen belts. The sampling frequency is 200 Hz for all signals. The 
dataset contains three major types of sleep tests: diagnostic, full-night continuous positive airway 
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pressure (CPAP), and split-night CPAP. PSGs were annotated in 30-second non-overlapping epochs 
according to AASM standards as one of the five stages: wake (W), non-REM stage 1 (N1), non-REM stage 
2 (N2), non-REM stage 3 (N3), and rapid eye movement (REM). Seven sleep technicians in total 
annotated the dataset, with one technician per PSG. 
The entire dataset includes 10,121 PSGs; 9,644 were exported successfully without time mismatch or 
missing sleep stage annotations. We included atrial fibrillation cases because the deep learning network 
is supposed to work with heterogeneous data. We excluded PSGs with fewer than 100 artifact-free 30-
second epochs, resulting in 8,682 PSGs. The dataset is summarized in Table 1. 
Table 1. Dataset Summary. 
Characteristics Value 
Number of PSGs 8,682 
Number of patients 7,208 
Age: year, median (IQR) 53 (41 – 63) 
Sex: number (percentage of all patients) 
    Female 2,997 (41.6%) 
    Male 4,189 (58.1%) 
    Unknown due to human error 22 (0.3%) 
BMI: kg/m2, median (IQR) 31 (27 – 36) 
Type of Test: number (percentage of all patients) 
    Diagnostic 3,571 (49.5%) 
    All night CPAP 1,751 (24.3%) 
    PSG split night 1,798 (24.9%) 
    Extended EEG-sleep montage 76 (1.1%) 
    Bedside 9 (0.1%) 
    Research 3 (0.04%) 
Apnea-Hypopnea Index (AHI, events / hour) : number (percentage of all patients) 
    Normal (AHI < 5) 2,879 (39.9%) 
    Mild (5 ≤ AHI < 15) 1,995 (27.7%) 
    Moderate (15 ≤ AHI < 30) 1,468 (20.4%) 
    Severe (AHI ≥ 30) 866 (12.0%) 
Respiratory Disturbance Index (RDI, events / hour) 15.0 (5.8 – 28.4) 
Periodic Limb Movement Index (PLMI, events / hour) 10.4 (3.1 – 28.3) 
Outpatient Medication Listing, by Category 
    Systemic 4523 (62.7%) 
    Hypertension 2755 (38.2%) 
    Sleeping 2187 (30.3%) 
    Antidepressant 1874 (26.0%) 
    Neuroactive 1365 (18.9%) 
    Benzodiazepine 1297 (18.0%) 
    Diabetic 802 (11.1%) 
    RLS/PLMS 688 (9.5%) 
    Opiate 548 (7.6%) 
    Z-drug 348 (4.8%) 
    Stimulant 310 (4.3%) 
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Preprocessing 
Sleep staging was done in 30-second epochs following AASM standards. However, changes in heart 
rhythms and respiration often occur over longer time scales. For this reason, and to provide contextual 
information, our deep neural networks used information extending 120 seconds on both sides of each 
30-second epoch, creating a 270-second epoch (4.5min, nine 30-second epochs) centered on each 30-
second epoch to be scored. The goal of the deep neural networks presented herein is to classify the 
sleep stage of the middle 30-second epoch using information from the 270-second epoch. This is 
illustrated in Figure S1 in the supplementary material. 
When using ECG as the input, we identified 270-second epochs with amplitude larger than 6mV or 
standard deviation smaller than 5μV, as they are not physiologically possible. In each 270-second epoch 
we extracted timings of R peaks 18 and converted the ECG to a binary sequence, where R peaks are 
indicated by a “1” and all other points indicated by “0”. The 270-second epochs with spurious R peaks 
were identified using the ADARRI 19 method. 270-second epochs with less than 20 R peaks per minute 
were also identified, as they are not physiologically possible. About 25% of the 270-second epochs were 
identified as artifact. In total, there were 5,964,359 270-second epochs. 
When using chest and abdominal respiratory effort as the input, 270-second epochs with amplitude 
larger than 6mV or standard deviation smaller than 10μV were identified. Respiratory signals were 
down-sampled to 10Hz. About 10% of the 270-second epochs were identified as artifact. In total, there 
were 6,847,246 270-second epochs for the chest signal; and 6,749,286 270-second epochs for the 
abdominal signal. 
When using pairs of signals as the input, the 270-second epochs where any signal modality that meet 
the above criteria are identified as artifact. In any of above cases, the artifactual 270-second epochs 
were removed when training CNN, and remained when training LSTM to preserve the temporal context. 
 
Deep Network Architecture 
We trained five deep neural networks based on the following input signals and their combinations: 1) 
ECG; 2) CHEST (chest respiratory effort); 3) ABD (abdominal respiratory effort); 4) ECG+CHEST; and 5) 
ECG+ABD. Each deep neural network contained a feed-forward convolutional neural network (CNN) 
which learned features pertaining to each epoch, and a recurrent neural network (RNN), in this case 
long-short term memory (LSTM), to learn temporal patterns among consecutive epochs. 
The CNN of the network is similar to that in Hannun et al. 20. As shown in Figure 1A and Figure 1B, the 
network for a single type of input signal, i.e. ECG, CHEST or ABD, consists of a convolutional layer, 
several residual blocks and a final output block. For a network with both ECG and CHEST/ABD as input 
signals (Figure 1C), we first fixed the weights of the layers up to the 9th residual block (gray) for the ECG 
network and similarly fixed up to the 5th residual block (gray) for the CHEST/ABD network, concatenated 
the outputs, and then fed this concatenation into a subnetwork containing five residual blocks and a 
final output block. The numbers of fixed layers were chosen so that the outputs of layers from different 
modalities have the same shape (after padding zeros), and were then concatenated. 
The LSTM of the network has the same structure for different input signals. It is a bi-directional LSTM, 
where the context cells from the forward and backward directions are concatenated. For the network 
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with ECG as input, the LSTM has two layers with 20 hidden nodes in each layer. For CHEST and 
ECG+CHEST, the LSTM has three layers with 100 hidden nodes in each layer. For ABD and ECG+ABD, the 
LSTM has two layers with 100 hidden nodes in each layer. The number of LSTM layers, number of hidden 
nodes, and dropout rate were determined by the method described in the next subsection. 
 
Figure 1. Deep neural network architecture. (A and B) CNN architecture using ECG, or CHEST or ABD as 
input. The numbers between blocks are the shapes of the output for each input 270-second epoch. For 
example, “320×4” means 320 channels and four time points. “17@64” in the convolution layers means 
kernel size 17 points and 64 kernels. The repetition number of the residual blocks (Res Block) is marked 
above each block. Arrows indicate the flow of network activations. (C) The CNN architecture when using 
multiple signals as input. Gray blocks mean their weights are obtained from network trained in (A) and 
(B), then fixed during training the network. (D) RNN architecture, which uses the output from the CNN 
from every 270-second epoch (corresponding to a 30-second epoch). The output is fed into a 
bidirectional LSTM, followed by concatenation of the activations from both directions, and finally into a 
dense layer. The legends on the right show the detailed structure of the residual block and final output 
block. Inside each residual block, the first convolution layer subsamples the input by 4 (stride = 4) and 
the max pooling skip-layer connection also subsamples the input by 4. 
 
Training and Evaluating the Network 
We randomly split the PSGs into a training set of 6,682 PSGs, a validation set of 1,000 PSGs and a testing 
set of 1,000 PSGs. Due to the large amount of data, we expect the random split should give similar 
distribution of the variables across these sets. We first trained the CNN, then the LSTM using the 
outputs from the CNN. The objective function of both CNN and LSTM is cross-entropy, a measure of the 
distance between two categorical distributions for classification. The networks were trained with a mini-
batch size of 32, maximum epochs of 10, and learning rate 0.001 (as commonly used in deep learning). 
The LSTM was trained using sequences of 20 epochs (10min). We set the number of LSTM layers, 
number of hidden nodes, and the dropout rate as the combination that minimizes the objective function 
on the validation set. 
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Some sleep stages occur more frequently than others. For example, people spend about 50% of sleep in 
N2 and 20% in N3. To prevent the network from simply learning to report the dominant stage, we 
weighed each 270-second input signal in the objective function by the inverse of the number of epochs 
in each sleep stage within the training set. 
For the performance metrics on the testing set, we used confusion matrices and Cohen’s kappa. We 
show performance for staging five sleep stages according to the AASM standards (W, N1, N2, N3, R), and 
we additionally collapse these stages into 3 sleep super-stages, in two different ways. The first set of 
super-stages is “awake or drowsy” (W+N1) vs. “sleep” (N2+N3) vs. “REM sleep” (R), and The second set 
of super-stages is “awake” (W) vs. “NREM sleep” (N1+N2+N3) vs. “REM sleep” (R). We obtained 95% 
confidence intervals for kappa values by bootstrapping (sample with replacement) 1,000 times. 
 
Results 
Overall Staging Performance 
In Figure 2, we show the confusion matrices for predicting all five sleep stages with different input 
signals. Using both ECG and ABD as input signals yields the best prediction results on the testing set. This 
network is correct in 81.8% of wake, 55.8% of N1, 66.3% of N2, 66.6% of N3 and 92.2% of REM epochs. 
Most misclassifications are found between W vs. N1, N1 vs. N2, and N2 vs. N3. For example, 31% of N3 
epochs are misclassified as N2, and 34% of N1 epochs are misclassified as either W or N2.  This limitation 
is reduced when grouping the sleep stages as in Figure 3 and Figure 4, so that both epochs of REM and 
NREM can be classified correctly with greater than 80% accuracy. 
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Figure 2. Five-stage classification confusion matrices, comparing staging by sleep technicians vs. network 
predictions on the 1000-PSG testing set for different input signals. Each row in the confusion matrix is 
the sleep stage annotated by the technician, while each column is the network prediction. The numbers 
are percentages. 
 
Figure 3. Three-stage classification confusion matrices, comparing staging by sleep technicians vs. 
network predictions on the 1000-PSG testing set for different input signals. The 3 “super-stages” here 
are: “awake or drowsy” (W+N1) vs. “sleep” (N2+N3) vs. “REM sleep” (R).  
 
Figure 4. Three-stage classification confusion matrices, comparing staging by sleep technicians vs. 
network predictions on the 1000-PSG testing set for different input signals. The 3 “super-stages” here 
are: “awake” (W) vs. “NREM sleep” (N1+N2+N3) vs. “REM sleep” (R). 
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For every choice of input signal, we calculated Cohen’s kappa, a statistic for assessing inter-reader 
agreement, and the corresponding 95% confidence intervals. These are shown in Table 2. ECG+ABD has 
the highest kappa, with values of 0.6 (all five stages), 0.74 (W+N1 vs. N2+N3 vs. REM) and 0.762 (Wake 
vs. NR vs. REM). Since the testing set has 1,000 PSGs (6.6×105 30-second epochs), the confidence 
interval is narrow. Therefore the differences between kappa values are all significant at 0.05 level. 
Table 2. Cohen’s kappa on the 1000-PSG testing set using different input signals. 
Input Signal 5 Stages 
3 Stages 
W+N1 vs. N2+N3 vs. R W vs. NR vs. R 
ECG 0.494 (0.492 – 0.495) 0.649 (0.647 – 0.65) 0.649 (0.647 – 0.651) 
CHEST 0.565 (0.563 – 0.566) 0.708 (0.707 – 0.709) 0.707 (0.706 – 0.709) 
ABD 0.579 (0.578 – 0.581) 0.725 (0.723 – 0.726) 0.738 (0.736 – 0.739) 
ECG + CHEST 0.506 (0.504 – 0.507) 0.648 (0.646 – 0.65) 0.661 (0.659 – 0.663) 
ECG + ABD 0.600 (0.599 – 0.602) 0.740 (0.738 – 0.741) 0.762 (0.76 – 0.763) 
 
Staging Performance on Different Groups of Participants 
In Table 3, we show Cohen’s kappa for different population groups in the testing set using ECG+ABD as 
the input signals. Kappa is lower in the elderly (≥ 60 years) and in people with higher Apnea-Hypopnea 
Index (AHI), compared to the respective control groups. Split-night studies have lower kappa values than 
diagnostic or CPAP nights due to different patterns before and after applying CPAP. Note again that due 
to the large number of epochs in the testing set, confidence intervals are narrow, and all comparisons 
are statistically significant at 0.05 level. The Cohen’s kappa for different population groups in the testing 
set using other input signals are shown in Table E1-E4 in the supplementary material. 
While performance is reduced with increasing AHI, the network still achieves Cohen’s kappa of 0.574 for 
five stages; and more than 0.7 for three super-stages for severe apnea. We interpret this to mean that 
either autonomic features characteristic of stages are independent of sleep apnea, or more likely, that 
the network has learned normal, apneic, and other pathological patterns of the respiration signals 
change according to sleep stage.  For example, REM and NREM interruptions in breathing may have 
distinct distributions of features such as event duration. 
Table 3. Cohen’s kappa in different groups in the 1000-PSG testing set using ECG + ABD as input. 
Category Group 5 stages 
3 stages 
W+N1 vs. 
N2+N3 vs. R 
W vs. NR vs. R 
Age 
Young: 18 ≤ Age < 40 0.622 0.760 0.773 
Middle: 40 ≤ Age < 60 0.598 0.736 0.761 
Old: Age ≥ 60 0.576 0.713 0.742 
Sex 
Male 0.594 0.728 0.755 
Female 0.602 0.746 0.763 
BMI (kg/m2) 
Normal: 18.5 ≤ BMI < 25 0.613 0.737 0.752 
Overweight: BMI ≥ 25 0.596 0.736 0.760 
Type of Test 
Diagnostic 0.600 0.738 0.756 
All Night CPAP 0.608 0.758 0.770 
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Split Night 0.584 0.707 0.752 
AHI 
(per hour) 
Normal: AHI < 5 0.608 0.760 0.773 
Mild: 5 ≤ AHI < 15 0.604 0.746 0.750 
Moderate: 15 ≤ AHI < 30 0.600 0.733 0.752 
Severe: AHI ≥ 30 0.574 0.717 0.742 
Periodic 
limb 
movement 
(per hour) 
Normal: PLM < 5 0.606 0.736 0.765 
Mild: 5 ≤ PLM < 15 0.600 0.746 0.767 
Moderate: 15 ≤ PLM < 30 0.600 0.733 0.752 
Severe: PLM ≥ 30 0.574 0.717 0.742 
Medication 
Antidepressant 0.588 0.736 0.756 
Benzodiazepine 0.602 0.750 0.761 
Diabetic 0.589 0.757 0.770 
Herbal 0.596 0.745 0.743 
Hypertension 0.595 0.732 0.758 
Neuroleptic 0.588 0.716 0.749 
Opiate 0.600 0.721 0.766 
Neuroactive 0.598 0.736 0.762 
Systemic 0.599 0.740 0.766 
RLS/PLMS 0.608 0.755 0.773 
Sleeping 0.610 0.750 0.763 
Stimulant 0.603 0.740 0.774 
 Z-drug 0.627 0.765 0.774 
 
Staging Performance on Individual PSGs 
In Figure 5, we show the histogram of Cohen’s kappa of each individual PSG using both ECG and ABD as 
input. The results indicate a fair amount of heterogeneity between PSGs, where the lowest extreme has 
negative kappa values around -0.1 and the highest extreme has kappa values around 0.9. In Figure S2 in 
the supplementary material, we show the Cohen’s kappa of each individual PSG using all signal types. 
 
Figure 5. Histogram of Cohen’s kappa values for individual PSGs using both ECG and ABD as input. The 
distributions are right-skewed. 
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Dependence on temporal precision of R-peak timing in the ECG 
In face of signal noise, the deep learning network should learn robust patterns of the ECG R peak time 
series. To validate its robustness to signal noise, we simulated noise that preserves the mean but 
corrupts higher order pattern of the ECG R peaks. In Figure S3 of the supplementary material, we can 
see that adding zero-mean Gaussian jitter to the R peaks causes performance to drop progressively as 
the standard deviation of the jitter increases. 
 
Signal Examples 
To gain some insight into the differences in breathing and heart rhythms that the deep neural network is 
using to distinguish sleep stages, we show some example whole night recordings from the 1000-PSG 
testing set in Figure 6, Figure 7, and Figure 8. These examples are selected as “typical”, meaning that 
they have the closest Cohen’s kappa compared to the overall kappa across the testing set. The 60-
second signal examples in Panel C are the signals where the deep neural network assigns the highest 
probability to the correct sleep stage within the recording. We can see a visible correspondence 
between the spectrogram and the sleep stages, as well as the mismatch between the spectrogram and 
EEG-based sleep stage. For example, in Figure 8, around 2 hours and 4.5 hours, the spectrogram of heart 
rate variability shows loss of very low frequency power, which is classified by the network as N3, but the 
EEG-based sleep stages contain both N2 and N3. More illustrations of the trained deep neural networks 
are shown in Figure S4-S12 of the supplementary material. 
 
Figure 6. An example 47-year male. (A) The sleep stages over the whole night annotated by the 
technician (hypnogram). (B) The predicted sleep stages from the deep neural network using ABD 
respiration as input. (C) Example 60-second ABD segment from each sleep stage which is correctly 
classified and has the highest predicted probability of that stage. Different colors correspond to the 
triangle markers on other panels, which indicate the location of the example in the whole night 
recording. The number above each example signal indicates the probability of being that stage as 
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predicted by the deep learning network. (D) The spectrogram of the ABD respiratory signal. The y-axis 
indicates the frequency. 
 
Figure 7. Similar to Figure 6, showing an example 42-year female using CHEST respiration as input. The 
scaling of the signals in Panel C is the same as in Figure 6, but amplitude of these example signal itself 
happens to be smaller. It is possible that other epochs have larger or similar amplitude compared to 
Figure 6. 
 
Figure 8. Similar to Figure 6, showing an example 39-year female using the R peaks from ECG as input. 
Panel C shows the R peaks represented as a binary sequence (see Methods). Panel D shows the 
spectrogram of the R peak intervals 21. 
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Discussion 
We hypothesize that it is possible to accurately stage sleep based on the electrocardiogram (ECG) and 
respiratory signals using deep learning. Our key findings are: 1) ECG and respiratory signals contain 
substantial information about sleep stages; 2) reduced staging accuracy is associated with older age 
and/or more severe sleep apnea, although the networks still perform well on signals from patients with 
advanced age and high AHI; 3) using deep learning, the staging performance is robust for a wide range 
of typical sleep disorders like OSA and PLMS, and commonly used medications; 4) collapsing certain 
stages of sleep/wake (e.g., N1 with wake and N2 with N3) results in greater staging agreement. 
Previous studies comparable to ours are summarized in Table 4.  Some prior studies have also sought to 
stage sleep from ECG and respiration using deep neural networks. However, these studies suffered from 
small sample sizes and limiting generalizability. Only one prior study used more than 100 participants for 
training and evaluation. The large sample size of training and testing sets in the present study provides 
more robust results compared to prior literature, and is expected to increase generalizability when 
applied to heterogeneous / external populations. 
Table 4. Related work in the literature.  
Author 
(year) 
Dataset size 
Performance 
(κ is Cohen’s kappa) 
Type of Signal Features 
Sady et al. 
2013 12 
13 
participants 
3 stages (W, NREM, REM): 
accuracy=78% 
5 stages (W, N1, N2, N3, REM): 
accuracy=62% 
Photo-
Plethysmogram, 
hemoglobin oxygen 
saturation, 
pneumotachograph 
Heartbeat 
interval, time 
domain 
respiratory 
signals. 
Long et al. 
2014 22 
48 
participants 
3 stages (W, NREM, REM): 
κ=0.48 
4 stages (W, light sleep, deep 
sleep, REM): κ =0.41 
Respiratory effort 
Time domain, 
dissimilarity 
measure 
Fonseca et 
al. 
2015 23 
48 
participants 
4 stages (W, light sleep, deep 
sleep, REM): κ=0.49, 
accuracy=69% 
3 stages (W, NREM, REM): 
κ=0.56 
Accuracy=80% 
ECG + Respiratory 
inductance 
plethysmography 
Time and 
frequency 
domain, 
nonlinear 
Zhao et al. 
2017 24 
25 
participants, 
100 nights 
4 stages (W, N1+N2, N3, REM): 
κ=0.70, 
accuracy=79.8% 
Radio frequency 
signal reflected off 
body (heartbeat, 
respiration) 
Radio 
frequency 
spectrogram 
Zhang et al. 
2017 25 
37,000 
epochs 
5 stages (W, N1, N2, N3, REM): 
Precision = 53.9% 
Recall = 56.0% 
F1 score = 53.2% 
Heart rate derived 
from a wearable 
device 
Frequency 
domain 
(DCT) 
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Radha et al. 
2018 26 
ECG: 352 
participants, 
PPG: 60 
participants 
ECG: 6 stages (W, S1, S2, S3, 
S4, REM), κ=0.61 and 
accuracy=76.30% 
PPG: 5 stages (W, N1, N2, N3, 
REM), κ=0.63 and 
accuracy=74.65% 
ECG and PPG 
Selected 
features from 
time and 
frequency 
domain 
 
Sleep staging based on ECG and respiration has lower performance compared to using EEG. We 
previously performed EEG-based sleep staging with a deep neural network trained on data from the 
same set of patients used in the present work. This achieves performance similar to human inter-rater 
agreement 17. This is not surprising since sleep technicians stage sleep mainly using EEG based on the 
AASM guideline. 
The improvement in staging performance when collapsing certain stages of sleep into super-stages may 
reflect information regarding the true biology of sleep states. N1 is an unstable transitional state with 
low probability and non-distinct EEG features. About half of sleep is N2, and can show both stable and 
unstable characteristics, such as cyclic alternating pattern, apneic, or stable breathing in patients with 
sleep apnea. Different methods to characterize sleep depth and quality are available, and it will be 
important in future work to investigate whether further parsing of NREM sleep is meaningful using 
machine learning combined with methods such as the Odds Ratio Product of NREM sleep depth 27 or 
ECG-cardiopulmonary coupling 8. 
The mild degradation of performance with age is not surprising when using conventional sleep stages as 
the ground truth. The reduction of N3 with age (mainly in males) is not accompanied by equal and 
simultaneous reductions in stable N2 – thus, older individuals with equally reduced N3 may have very 
different N2 quality. By contrast, stable N2 and N3 may have very similar or identical cardiorespiratory 
signatures, making it difficult or impossible for deep learning models to reliably distinguish them. Thus 
“errors” in discriminating these stages may reflect that EEG-based annotation in the reference standard 
is somewhat orthogonal to autonomic fluctuations. 
Estimation of sleep states from cardiac and respiratory signals can simplify sleep tracking in health and 
disease, especially in environments like an intensive care unit (ICU) or hospitalized patients in general, 
when the model is trained with enough ICU patients who receive various heart rate or blood pressure 
medications. 
Limitations of our analysis are as follows. 1) Our dataset includes only adults, and generalizability to the 
pediatric group will require additional study. 2) The 30-second epoch-based scoring of sleep limits the 
fine-grained analysis of sleep stages. This is especially true when sleep fragmenting conditions are 
present, where a given 30-second epoch may have features of multiple states. Moreover, boundary 
zones may be amplified, such as transitions between wake-REM and NREM in the presence of sleep 
apnea in REM sleep. Such periods will introduce “error” in machine learning analyses, though these are 
biological features of sleep fragmentation rather than measurement or characterization error, such as 
arousal, apnea, or limb movement. 3) Due to the “black-box” nature of deep neural networks, there is 
limited insight into what the networks use as key features. Future work to interpret what the networks 
have learned (beyond Figure 6, Figure 7, Figure 8, and Figure S4-S12 in the supplementary material) is 
needed. (4) 1-fold validation (single training-validation-testing split) is used. Although this is the 
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common practice in large datasets, it is nevertheless less biased to use cross-validation on multiple 
folds. 
In conclusion, utilizing a large-scale dataset consisting of 8,682 PSGs, we have developed a set of deep 
neural networks to classify sleep stages from ECG and/or respiration. ECG and respiratory effort provide 
substantial information about sleep stages. The best staging performance is obtained using both ECG 
and abdominal respiration. Staging performance depends to some extent on age, apnea-hypopnea 
index, and sleep study type. 
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Supplementary Figures 
 
 
Figure S1. Illustration of signal segmentation. 
 
 
Figure S2. The histogram of Cohen’s kappa of individual PSGs for different input signals and different 
combinations of sleep stages. 
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Figure S3. Cohen’s kappa when applying zero-mean Gaussian jitter to the ECG R peaks. 
 
 
Figure S4. tSNE visualization of the last layer activation of the deep network that takes ECG as the input. 
Each point in the figure is a 270-second epoch. 
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Figure S5. tSNE visualization of the last layer activation of the deep network that takes chest repiration 
signal as the input. Each point in the figure is a 270-second epoch. 
 
 
Figure S6. tSNE visualization of the last layer activation of the deep network that takes abdominal 
repiration as the input. Each point in the figure is a 270-second epoch. 
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Figure S7. The kernels of the first convolution layer in the deep network that takes ECG as the input. 
 
 
Figure S8. The kernels of the first convolution layer in the deep network that takes chest respiration as 
the input. 
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Figure S9. The kernels of the first convolution layer in the deep network that takes abdominal 
respiration as the input. 
 
 
Figure S10. Examples of ABD signals for different sleep stages. These examples are selected based on 
having high probability according to the deep neural network in each of the 5 sleep stages. The signals 
are not necessarily from the same recording. 
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Figure S11. Examples of CHEST signals in different sleep stages, selected based on having high 
probability by the deep neural network. The signals are not necessarily from the same recording. 
 
 
Figure S12. Example ECG R peaks in different sleep stages, selected based on having high probability by 
the deep neural network. The signals are not necessarily from the same recording. 
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Supplementary Tables 
 
Table S1. Cohen’s kappa in different group in the 1000-PSG testing set using ECG as input. 
Category Group 5 stages 
3 stages 
W+N1 vs. 
N2+N3 vs. R 
W vs. NR vs. 
R 
Age 
Young: 18 ≤ Age < 40 0.54 0.715 0.717 
Middle: 40 ≤ Age < 60 0.514 0.672 0.685 
Elderly: Age ≥ 60 0.426 0.57 0.564 
Sex 
Male 0.483 0.636 0.644 
Female 0.51 0.673 0.67 
BMI (kg/m2) 
Normal: 18.5 ≤ BMI < 25 0.536 0.678 0.672 
Overweight: BMI ≥ 25 0.49 0.65 0.654 
Type of Test 
Diagnostic 0.508 0.667 0.667 
All Night CPAP 0.501 0.67 0.663 
Split Night 0.462 0.601 0.622 
AHI 
(per hour) 
Normal: AHI < 5 0.519 0.699 0.701 
Mild: 5 ≤ AHI < 15 0.499 0.655 0.639 
Moderate: 15 ≤ AHI < 30 0.471 0.615 0.621 
Severe: AHI ≥ 30 0.427 0.532 0.603 
Periodic limb 
movement 
(per hour) 
Normal: PLMI < 5 0.497 0.656 0.676 
Mild: 5 ≤ PLMI < 15 0.512 0.667 0.669 
Moderate: 15 ≤ PLMI < 30 0.502 0.664 0.649 
Severe: PLMI ≥ 30 0.459 0.609 0.611 
Medication 
Antidepressant 0.489 0.651 0.652 
Benzodiazepine 0.501 0.674 0.662 
Diabetic 0.501 0.673 0.668 
Herbal 0.484 0.65 0.639 
Hypertension 0.495 0.649 0.655 
Neuroleptic 0.483 0.664 0.674 
Opiate 0.476 0.624 0.626 
Neuroactive 0.5 0.648 0.661 
Systemic 0.496 0.656 0.663 
RLS/PLMS 0.515 0.647 0.657 
Sleeping 0.499 0.669 0.66 
Stimulant 0.507 0.671 0.646 
Z-drug 0.526 0.692 0.682 
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Table S2. Cohen’s kappa in different group in the 1000-PSG testing set using CHEST as input. 
Category Group 5 stages 
3 stages 
W+N1 vs. 
N2+N3 vs. R 
W vs. NR vs. 
R 
Age 
Young: 18 ≤ Age < 40 0.581 0.728 0.728 
Middle: 40 ≤ Age < 60 0.569 0.709 0.713 
Old: Age ≥ 60 0.546 0.691 0.689 
Sex 
Male 0.558 0.701 0.704 
Female 0.573 0.719 0.716 
BMI (kg/m2) 
Normal: 18.5 ≤ BMI < 25 0.554 0.697 0.692 
Overweight: BMI ≥ 25 0.567 0.71 0.711 
Type of Test 
Diagnostic 0.57 0.714 0.713 
All Night CPAP 0.564 0.719 0.702 
Split Night 0.553 0.685 0.707 
AHI 
(per hour) 
Normal: AHI < 5 0.576 0.734 0.725 
Mild: 5 ≤ AHI < 15 0.572 0.714 0.708 
Moderate: 15 ≤ AHI < 30 0.555 0.688 0.696 
Severe: AHI ≥ 30 0.517 0.628 0.68 
Periodic limb 
movement 
(per hour) 
Normal: PLMI < 5 0.556 0.698 0.71 
Mild: 5 ≤ PLMI < 15 0.576 0.715 0.709 
Moderate: 15 ≤ PLMI < 30 0.576 0.72 0.716 
Severe: PLMI ≥ 30 0.551 0.698 0.699 
Medication 
Antidepressant 0.573 0.72 0.718 
Benzodiazepine 0.572 0.714 0.706 
Diabetic 0.561 0.708 0.707 
Herbal 0.586 0.728 0.713 
Hypertension 0.565 0.704 0.709 
Neuroleptic 0.532 0.691 0.689 
Opiate 0.576 0.709 0.704 
Neuroactive 0.573 0.713 0.72 
Systemic 0.564 0.706 0.71 
RLS/PLMS 0.58 0.725 0.726 
Sleeping 0.572 0.719 0.713 
Stimulant 0.581 0.722 0.7 
Z-drug 0.581 0.72 0.709 
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Table S3. Cohen’s kappa in different group in the 1000-PSG testing set using ABD as input. 
Category Group 5 stages 
3 stages 
W+N1 vs. 
N2+N3 vs. R 
W vs. NR vs. 
R 
Age 
Young: 18 ≤ Age < 40 0.584 0.737 0.753 
Middle: 40 ≤ Age < 60 0.586 0.728 0.746 
Old: Age ≥ 60 0.551 0.698 0.705 
Sex 
Male 0.574 0.719 0.737 
Female 0.577 0.725 0.732 
BMI (kg/m2) 
Normal: 18.5 ≤ BMI < 25 0.552 0.684 0.679 
Overweight: BMI ≥ 25 0.579 0.727 0.743 
Type of Test 
Diagnostic 0.584 0.724 0.733 
All Night CPAP 0.578 0.738 0.734 
Split Night 0.555 0.698 0.737 
AHI 
(per hour) 
Normal: AHI < 5 0.584 0.742 0.741 
Mild: 5 ≤ AHI < 15 0.585 0.734 0.739 
Moderate: 15 ≤ AHI < 30 0.563 0.696 0.723 
Severe: AHI ≥ 30 0.533 0.651 0.725 
Periodic limb 
movement 
(per hour) 
Normal: PLMI < 5 0.574 0.726 0.748 
Mild: 5 ≤ PLMI < 15 0.583 0.73 0.738 
Moderate: 15 ≤ PLMI < 30 0.579 0.714 0.728 
Severe: PLMI ≥ 30 0.559 0.7 0.714 
Medication 
Antidepressant 0.574 0.731 0.743 
Benzodiazepine 0.595 0.738 0.749 
Diabetic 0.574 0.736 0.74 
Herbal 0.605 0.741 0.75 
Hypertension 0.576 0.719 0.738 
Neuroleptic 0.527 0.695 0.715 
Opiate 0.585 0.722 0.74 
Neuroactive 0.581 0.729 0.743 
Systemic 0.578 0.726 0.744 
RLS/PLMS 0.58 0.739 0.74 
Sleeping 0.589 0.737 0.745 
Stimulant 0.604 0.745 0.769 
 Z-drug 0.602 0.75 0.756 
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Table S4. Cohen’s kappa in different group in the 1000-PSG testing set using ECG + CHEST as input. 
Category Group 5 stages 
3 stages 
W+N1 vs. 
N2+N3 vs. R 
W vs. NR vs. 
R 
Age 
Young: 18 ≤ Age < 40 0.539 0.691 0.708 
Middle: 40 ≤ Age < 60 0.506 0.645 0.657 
Old: Age ≥ 60 0.468 0.603 0.621 
Sex 
Male 0.492 0.633 0.647 
Female 0.518 0.659 0.673 
BMI (kg/m2) 
Normal: 18.5 ≤ BMI < 25 0.54 0.672 0.682 
Overweight: BMI ≥ 25 0.499 0.642 0.656 
Type of Test 
Diagnostic 0.518 0.661 0.674 
All Night CPAP 0.504 0.652 0.644 
Split Night 0.472 0.602 0.642 
AHI 
(per hour) 
Normal: AHI < 5 0.521 0.677 0.683 
Mild: 5 ≤ AHI < 15 0.518 0.657 0.651 
Moderate: 15 ≤ AHI < 30 0.472 0.604 0.637 
Severe: AHI ≥ 30 0.451 0.554 0.627 
Periodic limb 
movement 
(per hour) 
Normal: PLMI < 5 0.5 0.643 0.668 
Mild: 5 ≤ PLMI < 15 0.52 0.655 0.661 
Moderate: 15 ≤ PLMI < 30 0.511 0.657 0.661 
Severe: PLMI ≥ 30 0.475 0.611 0.632 
Medication 
Antidepressant 0.508 0.66 0.664 
Benzodiazepine 0.519 0.663 0.673 
Diabetic 0.488 0.658 0.658 
Herbal 0.547 0.687 0.719 
Hypertension 0.49 0.631 0.641 
Neuroleptic 0.462 0.633 0.679 
Opiate 0.499 0.613 0.644 
Neuroactive 0.504 0.648 0.667 
Systemic 0.499 0.643 0.656 
RLS/PLMS 0.516 0.671 0.681 
Sleeping 0.517 0.667 0.679 
Stimulant 0.539 0.677 0.683 
 Z-drug 0.547 0.684 0.703 
 
 
 
